We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+29%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$1.94B
Cap. Flow
-$956M
Cap. Flow %
-6.31%
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$148M
2
HUM icon
Humana
HUM
+$109M
3
META icon
Meta Platforms (Facebook)
META
+$102M
4
MSI icon
Motorola Solutions
MSI
+$89.2M
5
LOW icon
Lowe's Companies
LOW
+$82M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$208M
2
JNJ icon
Johnson & Johnson
JNJ
+$190M
3
PFE icon
Pfizer
PFE
+$166M
4
NVDA icon
NVIDIA
NVDA
+$154M
5
ADBE icon
Adobe
ADBE
+$134M

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Technology 18.34%
3 Consumer Discretionary 12.92%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POST icon
701
Post Holdings
POST
$3.45B
$1.26M 0.01%
+21,939
New +$1.28M
KIDS icon
702
OrthoPediatrics
KIDS
$608M
$1.26M 0.01%
+28,755
New +$1.29M
SIVB
703
DELISTED
SVB Financial Group
SIVB
$1.26M 0.01%
+5,824
New +$1.12M
CDNA icon
704
CareDx
CDNA
$2.44B
$1.24M 0.01%
+34,996
New +$996K
MYGN icon
705
Myriad Genetics
MYGN
$311M
$1.24M 0.01%
+109,440
New +$1.55M
ETR icon
706
Entergy
ETR
$49.3B
$1.24M 0.01%
+26,380
New +$1.28M
PCVX icon
707
Vaxcyte
PCVX
$8.67B
$1.23M 0.01%
+38,856
New +$1.25M
IOSP icon
708
Innospec
IOSP
$2.29B
$1.22M 0.01%
15,789
+4,357
+38% +$319K
UTZ icon
709
Utz Brands
UTZ
$1.25B
$1.22M 0.01%
+88,925
New +$1.03M
BBWI icon
710
Bath & Body Works
BBWI
$3.89B
$1.21M 0.01%
+99,967
New +$1.11M
CNMD icon
711
CONMED
CNMD
$1.48B
$1.21M 0.01%
16,805
-19,152
-53% -$1.33M
ECHO
712
EchoStar
ECHO
$25.9B
$1.2M 0.01%
+42,972
New +$1.31M
AWI icon
713
Armstrong World Industries
AWI
$7.75B
$1.2M 0.01%
+15,399
New +$1.17M
COF icon
714
Capital One
COF
$134B
$1.2M 0.01%
+19,168
New +$1.19M
AVYA
715
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$1.2M 0.01%
+96,765
New +$1.11M
KGC icon
716
Kinross Gold
KGC
$32.5B
$1.19M 0.01%
165,409
-63,900
-28% -$415K
ACAD icon
717
Acadia Pharmaceuticals
ACAD
$5.06B
$1.18M 0.01%
+24,422
New +$1.17M
AEM icon
718
Agnico Eagle Mines
AEM
$91.4B
$1.18M 0.01%
18,498
-202,222
-92% -$12M
AIZ icon
719
Assurant
AIZ
$14.2B
$1.18M 0.01%
+11,429
New +$1.18M
LKFT
720
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$1.18M 0.01%
+5,975
New +$1.24M
BNR
721
Burning Rock Biotech
BNR
$115M
$1.17M 0.01%
+4,313
New +$1.18M
BNTX icon
722
BioNTech
BNTX
$23.3B
$1.16M 0.01%
+17,428
New +$870K
WSFS icon
723
WSFS Financial
WSFS
$4.12B
$1.15M 0.01%
+40,212
New +$1.06M
CCEP icon
724
Coca-Cola Europacific Partners
CCEP
$46.9B
$1.15M 0.01%
30,524
-16,787
-35% -$658K
SONO icon
725
Sonos
SONO
$1.83B
$1.15M 0.01%
78,658
-646,435
-89% -$6.87M
27 28
29
30 31

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace North America held 1,647 positions worth $15.1B, up 15% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America withdrew a net $956M in Q2 2020, closing 527 positions and reducing 312 holdings. Its most notable exit was Becton Dickinson, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Motorola Solutions worth $88.4M.

  • Marshall Wace North America's largest Q2 2020 buy was Motorola Solutions: 630,587 shares worth $88.4M.
  • Marshall Wace North America added most to JPMorgan Chase in Q2 2020, an estimated $148M increase.
  • Marshall Wace North America's biggest Q2 2020 reduction was Merck, cutting an estimated $208M.
  • Marshall Wace North America fully exited Becton Dickinson in Q2 2020, selling an estimated $86.4M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $15.1B portfolio in Q2 2020.
  • Marshall Wace North America opened 467 new positions and closed 527 in Q2 2020.
  • Marshall Wace North America's portfolio value rose 15% quarter-over-quarter to $15.1B.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.